LAQV REQUIMTE

(Chemical) Bonding is what makes life possible

Maria Enea

Back

Research group
Nanoplatforms for Life

Position
"BI" or other fellowships

Researcher IDT-4666-2017
Ciência IDD316-F276-24A5
M. Enea obtained a pre-Bologna (5 years) degree (300 ECTS recognized in Portugal) with final classification of 18 values (0-20 scale) in Pharmacy from the Faculty of Medicine and Pharmacy "Grigore T. Popa" Iasi, Romania.
She has a PhD in Sustainable Chemistry with the thesis: ‘Synthesis, characterization and safety evaluation of gold nanoparticles for biomedical applications’, with a scholarship financed by the Portuguese Foundation of Science and Technology PDQS PD/BD/109634/2015 in Toxicology Laboratory, FFUP.
Presently, she is a PhD researcher in the field of Nanobiotechnology with a special focus on `Gold nanoparticle-based molecular detection of metabolic diseases`, work developed in "Nanoplatforms for life" group (LAQVC-REQUIMTE- FCUP).

Representative Publications

Ethanol addictively enhances the in vitro cardiotoxicity of cocaine through oxidative damage, energetic deregulation, and apoptosis
10.1007/s00204-018-2227-7
Toxicological Evaluation of Luminescent Silica Nanoparticles as New Drug Nanocarriers in Different Cancer Cell Lines
10.3390/ma11081310
A multiparametric study of gold nanoparticles cytotoxicity, internalization and permeability using an in vitro model of blood-brain barrier. Influence of size, shape and capping agent
10.1080/17435390.2019.1621398
3,4-Methylenedioxymethamphetamine Hepatotoxicity under the Heat Stress Condition: Novel Insights from in Vitro Metabolomic Studies
10.1021/acs.jproteome.9b00741
Hepatic Metabolic Derangements Triggered by Hyperthermia: An In Vitro Metabolomic Study
10.3390/metabo9100228
A Metabolomic Approach for the In Vivo Study of Gold Nanospheres and Nanostars after a Single-Dose Intravenous Administration to Wistar Rats
10.3390/nano9111606
A new strategy for exploring the role of hyperthermia in MDMA-induced toxicity in primary mouse hepatic cells using GC-MS-based metabolomics